3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Myeloid
1
Endocrine
1
CNS
1
Conditions
Neoplasms
1
Interventions
pembrolizumab
26
Specimen Handling
22
Biopsy
22
Magnetic Resonance Spectroscopy
20
Paclitaxel
12
Standard of Care
10
Carboplatin
10
Blood Specimen Collection
10
Bevacizumab
10
atezolizumab
9
Nivolumab
9
Cisplatin
8
Radiosurgery
7
Pemetrexed
7
Capecitabine
7
Surveys and Questionnaires
6
Gemcitabine
6
Cyclophosphamide
6
trastuzumab deruxtecan
5
durvalumab
5
X-Rays
5
Taxes
5
Radiotherapy
5
Irinotecan
5
Fluorouracil
5
olaparib
4
niraparib
4
cabozantinib
4
Oxaliplatin
4
Leucovorin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Clinical Laboratory Techniques
×
Tumor-Agnostic
×
90 days
×
Clear all
NCT07543432
2026-04-21
STATIC
Stiftelsen Stockholms Sjukhem
Phase NA
Recruiting
80 enrolled